The burgeoning landscape of novel treatments for body management has seen the rise of both retatrutide and tirzepatide, both dual mechanism agonists targeting the GLP-1 and GIP receptors. While sharing a comparable https://lawsonaouv644369.wikifiltraciones.com/4276407/retatrutide_vs_tirzepatide_a_comparative_analysis